Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Feb;8(4):139.
doi: 10.21037/atm.2019.12.06.

Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer-reply to the editors

Nadina Tinsley  1 , Donna M Graham  1   2 , Natalie Cook  1   2
Affiliations
Comment

Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer-reply to the editors

Nadina Tinsley et al. Ann Transl Med. 2020 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Tinsley N, Zhou C, Tan G, et al. Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer. Oncologist 2020;25:55-63. 10.1634/theoncologist.2019-0160 - DOI - PMC - PubMed
    1. Reed JP, Devkota S, Figlin RA. Gut microbiome, antibiotic use, and immunotherapy responsiveness in cancer. Ann Transl Med 2019;7:S309. 10.21037/atm.2019.10.27 - DOI - PMC - PubMed
    1. Casadei C, Lolli C, Farolfi A. Immune-checkpoint inhibitors and the importance of concomitant medications: focus on antibiotics. Ann Transl Med 2019;7:S339. 10.21037/atm.2019.09.99 - DOI - PMC - PubMed
    1. Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 2018;359:91-7. 10.1126/science.aan3706 - DOI - PubMed
    1. Derosa L, Routy B, Kroemer G, et al. The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1. Oncoimmunology 2018;7:e1434468. 10.1080/2162402X.2018.1434468 - DOI - PMC - PubMed